Malaria
📧 Sign up to get email alerts when something new happens for Malaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: Understanding and Maximizing the Community Impact of Antimalarial Treatment (INDIE-SMC) [NA]
The INDIE-SMC trial led by the London School of Hygiene and Tropical Medicine has completed, investigating how antimalarial treatment affect…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults [Phase 2]
A Phase 2 clinical trial evaluating the safety and immunogenicity of the R21/Matrix-M malaria vaccine in healthy Thai adults has completed. …
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Burden of Schistosomiasis and Soil-transmitted Helminth Infections in Schoolchildren in Banfora, Burkina Faso
This clinical trial update reports on the burden of schistosomiasis and soil-transmitted helminth infections among schoolchildren in Banfora…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Under 12 Years at Four Sentinel Sites in Mozambique [NA]
This completed clinical trial evaluates the efficacy of artemether-lumefantrine for treating uncomplicated Plasmodium falciparum malaria in …
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Repellents as Added Control Measure to Long Lasting Insecticidal Nets [NA]
This clinical trial evaluated repellents added to long-lasting insecticidal nets for malaria control. The study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Pan-Malaria Transmission-Blocking Vaccine AnAPN1 [Phase 1]
Phase 1 trial of the AnAPN1 pan-malaria transmission-blocking vaccine has been completed.
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: VAC069: A Study of Blood-stage Controlled Human P. Vivax Infection [EARLY_Phase 1]
This update reports completion of VAC069, a Phase 1 study evaluating blood-stage controlled human Plasmodium vivax infection, with results p…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Chlorproguanil-Dapsone in Pregnant Women [Phase 1]
Phase 1 trial evaluating chlorproguanil-dapsone in pregnant women with malaria was terminated; no results were reported in the update.
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Pyronaridine in Healthy Adult Participants Infected With Blood Stage Malaria [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of Pyronaridine in healthy adult participants experimentally infected wi…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: L9LS MAb in Malian Adults [Phase 2]
Phase 2 trial results for the L9LS monoclonal antibody in Malian adults with malaria have been posted.
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK [EARLY_Phase 1]
Early-phase 1 study of the Pfs48/45 malaria vaccine candidate with Matrix-M adjuvant in the UK was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Village Malaria Worker Expansion
The study reports completion of the Village Malaria Worker expansion trial led by the University of Oxford, assessing strategies to address …
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) [Phase 3]
The BOHEMIA trial is a Phase 3 study of a broad one-health endectocide-based intervention for malaria, and the study status is completed. Th…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Parasite Clearance and Protection From Infection (PCPI) in Cameroon [Phase 3]
Phase 3 clinical trial in Cameroon evaluating Parasite Clearance and Protection From Infection (PCPI) for malaria has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Parasite Clearance and Protection From Infection (PCPI) in Zambia [Phase 3]
A Phase 3 trial in Zambia evaluating Parasite Clearance and Protection From Infection (PCPI) for malaria has completed, per the trial status…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Piperaquine Granule Formulation Relative Bioavailability and Food Effect Study in Healthy Volunteers. [Phase 1]
A Phase 1 study in healthy volunteers evaluated the relative bioavailability of a piperaquine granule formulation and the effect of food, wi…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Women [Phase 3]
Phase 3 clinical trial update evaluating the efficacy and safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian pregnant women wi…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Pharmacokinetics of Antimalarials in Breastfeeding Ugandan Mother-infant Pairs
This document provides an update on pharmacokinetic studies of antimalarial drugs in breastfeeding mother-infant pairs in Uganda. The study …
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Trial to Evaluate the Safety, Immunogenicity and Protective Efficacy of Three or Five Administrations of GAP3KO Sporozoites [Phase 1]
This update reports the completion of a Phase 1 trial evaluating the safety, immunogenicity, and protective efficacy of three or five admini…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: A Study to Determine if New Types of Malaria Vaccines Are Safe, Effective and Lead to Immunity in Kenyan Adults [Phase 2]
A Phase 2 malaria vaccine trial conducted in Kenyan adults has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults [Phase 1]
Phase 1 trial evaluating safety, tolerability, pharmacokinetics, and protective efficacy of MAM01 in healthy adults has been completed.
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Evaluation of Vector and Chemoprevention-based Interventions to Reduce Malaria Burden in Urban Daaras of Touba, Senegal [Phase 4]
A Phase 4 study evaluating vector control and chemoprevention strategies to reduce malaria burden in urban Daaras of Touba, Senegal has been…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West Africa [NA]
A completed trial evaluating how differential and systematic diagnosis of dengue, chikungunya, and malaria affects patient management and an…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Community Dynamics of Malaria Transmission and Mosquito Feeding in Bancoumana, Mali
This clinical trial update reports on the completion of a study examining community dynamics of malaria transmission and mosquito feeding in…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV367 [Phase 1]
First-in-human Phase 1 trial evaluating the safety, tolerability, and pharmacokinetics of MMV367 for malaria; the study is completed and res…